Dumlu, R.; Şahin, M.; Derin, O.; Gül, Ö.; Başgönül, S.; Zengin, R.; Arabacı, Ç.; Şimşek, F.; Gençer, S.; Kocagöz, A.S.;
et al. Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. Antibiotics 2024, 13, 990.
https://doi.org/10.3390/antibiotics13100990
AMA Style
Dumlu R, Şahin M, Derin O, Gül Ö, Başgönül S, Zengin R, Arabacı Ç, Şimşek F, Gençer S, Kocagöz AS,
et al. Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. Antibiotics. 2024; 13(10):990.
https://doi.org/10.3390/antibiotics13100990
Chicago/Turabian Style
Dumlu, Rıdvan, Meyha Şahin, Okan Derin, Özlem Gül, Sedef Başgönül, Rehile Zengin, Çiğdem Arabacı, Funda Şimşek, Serap Gençer, Ayşe Sesin Kocagöz,
and et al. 2024. "Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region" Antibiotics 13, no. 10: 990.
https://doi.org/10.3390/antibiotics13100990
APA Style
Dumlu, R., Şahin, M., Derin, O., Gül, Ö., Başgönül, S., Zengin, R., Arabacı, Ç., Şimşek, F., Gençer, S., Kocagöz, A. S., & Mert, A.
(2024). Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. Antibiotics, 13(10), 990.
https://doi.org/10.3390/antibiotics13100990
